hexamethylene bisacetamide has been researched along with phorbol 12,13-dibutyrate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumberg, PM; Dell'Aquila, ML; Herald, CL; Nguyen, HT; Pettit, GR | 1 |
1 other study(ies) available for hexamethylene bisacetamide and phorbol 12,13-dibutyrate
Article | Year |
---|---|
Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
Topics: Acetamides; Animals; Antineoplastic Agents; Bryostatins; Carcinogens; Cell Differentiation; Cell Line; Humans; Kinetics; Lactones; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Macrolides; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters | 1987 |